Scientists target cancer's weak spot: oxygen balance

NCT ID NCT06600568

Recruiting now Knowledge-focused Sponsor: Istituto Oncologico Veneto IRCCS Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated Jun 13, 2026 · Updated 25 times

Summary

This study looks for better ways to treat T-cell leukemia and lymphoma, a type of blood cancer. Researchers will test combinations of drugs that affect how cells handle oxygen-related stress, aiming to kill cancer cells while sparing healthy ones. The study involves 120 adults and uses lab-grown cells and patient samples to find the most promising treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for T-CELL LEUKEMIA/LYMPHOMA, ADULT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Istituto Nazionale Tumori Fondazione G.Pascale
RECRUITING

Naples, 80100, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••
Istituto Oncologico Veneto
RECRUITING

Padova, 35128, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

adult T-cell leukemia/lymphoma Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

T-CELL LEUKEMIA/LYMPHOMA, ADULT T-CELL LEUKEMIA/LYMPHOMA, ADULT